Bone infection, also known as osteomyelitis, is a serious condition characterized by the inflammation or infection of bone tissue. This can result from bacteria entering the bone through open fractures, surgical procedures, or bloodstream infections. Common causative bacteria include Staphylococcus aureus. Symptoms of bone infection may include localized pain, swelling, redness, and limited joint mobility. Systemic symptoms like fever and chills can also occur. Chronic or untreated cases may lead to bone destruction and the formation of abscesses. Diagnosis involves medical imaging, blood tests, and sometimes bone biopsies to identify the causative bacteria. Treatment typically includes prolonged courses of antibiotics, and in severe cases, surgical intervention may be necessary to remove infected tissue. Risk factors for bone infections include diabetes, immunocompromised conditions, and the presence of prosthetic devices. Preventive measures involve proper wound care, infection control practices during surgery, and managing underlying health conditions. Early detection and appropriate treatment are essential in managing bone infections and preventing complications. A multidisciplinary approach involving orthopedic surgeons and infectious disease specialists is often required for optimal outcomes.
Title : A universal AI design framework and brokerage platform for democratised manufacturing of mRNA therapeutics
Duccio Medini, BioForge, United States
Title : Personalized and Precision Medicine (PPM) via biodesign-driven translational applications and upgraded business modeling to secure the human biosafety: The next-step vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Development of VSV-vector based vaccine against H5N1 avian influenza by targeting both H5N1 hemagglutinin and matrix protein 2
Zhujun Ao, University of Manitoba, Canada
Title : A novel responsive microneedle platform for reliable drug and vaccine delivery
Huanhuan Li, Queen’s University Belfast, United Kingdom
Title : Emerging nanovaccine strategies for enhanced immune targeting and vaccine performance
Aysel Sadayli, V.Y. Axundov Scientific-Research Institute of Medical Prophylaxis, Azerbaijan
Title : The promise of nanotechnology in Personalized & Precision Medicine: Nano-driven precision vaccinomics of the future
Sergey V Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Reaching zero-dose children through adaptive immunization strategies in security-compromised areas of Zamfara State, Nigeria
Attahir Abubakar, Ahmadu Bello University, Nigeria
Title : Comparative efficacy of different H9N2 avian influenza virus inactivated vaccines using some commercially available adjuvants for superior control in broilers
Ayman H M El Deeb, Cairo University, Egypt
Title : Structure-based design and development of next-generation Respiratory Syncytial Virus (RSV) vaccine
Lei Chen, Yikang Biotech Suzhou Co., Ltd, China
Title : Unmasking urban immunization inequities: A cross-sectional LQAS analysis of zero-dose drivers in slum and non-slum settings of Uttar Pradesh, India
Ashish Kumar Maurya, John Snow India, India